Literature DB >> 12706881

Differential expression of GLUT12 in breast cancer and normal breast tissue.

Suzanne Rogers1, Susan E Docherty, John L Slavin, Michael A Henderson, James D Best.   

Abstract

Increased and deregulated expression of glucose transporters is a characteristic of cancer cells. We previously identified a novel glucose transporter protein, GLUT12, in the MCF7 malignant breast epithelial cell line. Here we present the first demonstration of GLUT12 expression in human breast tumours. Using immunohistochemistry and reverse transcription polymerase chain reaction, GLUT12 was detected in eight of ten invasive tumours. Ductal cell carcinoma in situ cells also stained strongly for GLUT12. Immunohistochemical staining for GLUT12 in benign ducts was less intense, with few positively stained cells. GLUT12 may have a role in hexose supply to breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706881     DOI: 10.1016/s0304-3835(03)00010-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

Review 1.  The facilitative glucose transporter GLUT12: what do we know and what would we like to know?

Authors:  Jonai Pujol-Giménez; Jaione Barrenetxe; Pedro González-Muniesa; Maria Pilar Lostao
Journal:  J Physiol Biochem       Date:  2012-10-03       Impact factor: 4.158

2.  Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.

Authors:  M A Kocdor; H Kocdor; J S Pereira; J E Vanegas; I H Russo; J Russo
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

3.  GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.

Authors:  Mark A White; Efrosini Tsouko; Chenchu Lin; Kimal Rajapakshe; Jeffrey M Spencer; Sandi R Wilkenfeld; Sheiva S Vakili; Thomas L Pulliam; Dominik Awad; Fotis Nikolos; Rajasekhara Reddy Katreddy; Benny Abraham Kaipparettu; Arun Sreekumar; Xiaoliu Zhang; Edwin Cheung; Cristian Coarfa; Daniel E Frigo
Journal:  Endocr Relat Cancer       Date:  2018-02-05       Impact factor: 5.678

4.  Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays.

Authors:  Rachel Airley; Andrew Evans; Ali Mobasheri; Stephen M Hewitt
Journal:  Ann Anat       Date:  2010-03-24       Impact factor: 2.698

Review 5.  Hepatic expression and cellular distribution of the glucose transporter family.

Authors:  Sumera Karim; David H Adams; Patricia F Lalor
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

Review 6.  Targeting metabolism in breast cancer: How far we can go?

Authors:  Jing-Pei Long; Xiao-Na Li; Feng Zhang
Journal:  World J Clin Oncol       Date:  2016-02-10

7.  Functional properties and genomics of glucose transporters.

Authors:  Feng-Qi Zhao; Aileen F Keating
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

8.  Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells.

Authors:  Yong Yang; Joy Wolfram; Kathryn Boom; Xiaohong Fang; Haifa Shen; Mauro Ferrari
Journal:  Cell Biochem Funct       Date:  2012-10-08       Impact factor: 3.685

Review 9.  Revisiting the seed and soil in cancer metastasis.

Authors:  Martin Mendoza; Chand Khanna
Journal:  Int J Biochem Cell Biol       Date:  2009-02-03       Impact factor: 5.085

10.  Metabolic control analysis of cellular respiration in situ in intraoperational samples of human breast cancer.

Authors:  Tuuli Kaambre; Vladimir Chekulayev; Igor Shevchuk; Minna Karu-Varikmaa; Natalja Timohhina; Kersti Tepp; Jelena Bogovskaja; Riina Kütner; Vahur Valvere; Valdur Saks
Journal:  J Bioenerg Biomembr       Date:  2012-07-27       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.